| 1. |
Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010:findings from the Global Burden of Disease Study 2010[J]. Lancet, 2013, 381(9882):1987-2015.
|
| 2. |
Liu L, Wang D, Wong KS, et al. Stroke and stroke care in China:huge burden, significant workload, and a national priority[J]. Stroke, 2011, 42(12):3651-3654.
|
| 3. |
Wang Y, Liao X, Zhao X, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China:analysis of the results from the Chinese National Stroke Registry (CNSR)[J]. Stroke, 2011, 42(6):1658-1664.
|
| 4. |
Dietl M1, Pohle R, Weing?rtner M, et al. Stroke etiology and long-term need of care in ischemic stroke patients[J]. Fortschr Neurol Psychiatr, 2009, 77(12):714-719.
|
| 5. |
Gao S, Wang YJ, Xu AD, et al. Chinese ischemic stroke subclassification[J]. Front Neurol, 2011, 15(2):1-6.
|
| 6. |
重組組織型纖溶酶原激活劑治療缺血性卒中共識專家組. 臨床應用rt-PA靜脈溶栓治療缺血性卒中專家共識[J]. 中華內科雜志, 2006, 45(7):613-614.
|
| 7. |
胡大一, 郭藝芳. 心房顫動抗凝治療中國專家共識[J]. 心腦血管病防治, 2012, 12(3):173-177.
|
| 8. |
他汀類藥物防治缺血性卒中/短暫性腦缺血發作專家共識組. 他汀類藥物防治缺血性卒中/短暫性腦缺血發作專家共識[J]. 中國卒中雜志, 2013, 8(7):565-575.
|
| 9. |
Cornett O, Ocava LC, Singh M, et al. Antithrombotic and thrombolytic therapy for ischemic stroke[J]. Cardiol Clin, 2008, 26(2):251-65.
|
| 10. |
周澤純, 田杏音. 心源性腦栓塞急性期的護理觀察[J]. 廣州醫藥, 2013, 44(5):71-72.
|
| 11. |
Fonarow GC, Zhao X, Smith EE, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemicstroke before and after a quality improvement initiative[J]. JAMA, 2014, 311(16):1632-40.
|
| 12. |
羅穎, 徐程瑩. 康復訓練和出院后康復督導對腦梗塞康復的影響[J]. 中華全科醫學, 2011, 9(10):1646-1647.
|